A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Completed · Phase 4

Conditions studied: Diabetes Mellitus, Type 2

In brief

In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.

Key facts

Study ID
NCT03724981
Run by
Eli Lilly and Company
People needed
312
Starts
2018-10-18
Expected to finish
2019-04-12
Last updated by the study team
2020-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.